NONA BIOSCIENCES
DEAD

Serial Number

97573031

Owner

Nona Biosciences US, Inc.

Attorney

Eric Lamb

Filing Date

Aug 31, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NONA BIOSCIENCES Trademark

Serial Number: 97573031

NONA BIOSCIENCES is a trademark filed by Nona Biosciences US, Inc. on August 31, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Nona Biosciences US, Inc. (9 trademarks)

Suite 355
Natick, MA 01760

Entity Type: 03

Trademark Details

Filing Date

August 31, 2022

Registration Date

Not Registered

Published for Opposition

September 5, 2023

Goods & Services

Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 2, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 2, 2025 ABN6
CORRECTED NOA E-MAILED
Dec 5, 2024 NOAC
DIVISIONAL PROCESSING COMPLETE
Dec 5, 2024 DPCC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 5, 2024 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 4, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Sep 24, 2024 DRRR
SOU EXTENSION 2 FILED
Sep 24, 2024 EXT2
TEAS REQUEST TO DIVIDE RECEIVED
Sep 24, 2024 ERTD
SOU TEAS EXTENSION RECEIVED
Sep 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 29, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 29, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 29, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2022 NWOS
NEW APPLICATION ENTERED
Sep 3, 2022 NWAP